Cryo-Cell makes it simple to do just that-by providing the safe collection and preservation of your newborn's precious stem cells. For more than a decade, Cryo-Cell and its worldwide affiliates have expertly processed over 135,000 newborn's cord blood for families just like yours. Cryo-Cell facilities are accredited by the AABB, registered with the FDA, certified to ISO9001:2000 standards, and operates in a cGMP/cGTP compliant facility.
Cryo-Cell International, Inc. was established in 1989 with a primary focus on the cryopreservation of umbilical cord (U-Cord®) stem cells for family use. Since our inception, we have been committed to the development and adoption of industry best practices and technologies. Ever-committed to the highest quality, we treat every specimen of umbilical cord blood as if it were our own. Every sample we receive, process and preserve represents a potentially life-saving treatment for a child. This concept fuels our resolve to only hire the most talented candidates, develop and implement the most effective training and continuously fine-tune our processes. From the design and specifications of our collection kit, to the choice of each supplier, our dedication to quality remains unwavering.
Saneron CCEL Therapeutics, Inc.
Cryo-Cell holds an equity position in Saneron CCEL Therapeutics (Saneron), a University of South Florida spin-out biotechnology company. Saneron is committed to advancing research using readily available, non-controversial cord blood stem cells. Saneron’s research focus is to actively seek new cellular therapy discoveries for treatment of and intervention in devastating, life-threatening illness and conditions such as heart attack, Alzheimer’s disease, stroke, and spinal cord injury. For more information, visit Saneron’s Web site: www.saneron-ccel.com
Cryo-Cell International, Inc.
700 Brooker Creek Blvd.
Suite 1800
Oldsmar, FL 34677
Phone: 813-749-2100
Toll Free: 800-786-7235
Fax: 813-855-4745
